Skip to main content
. 2021 Jun 16;8:676954. doi: 10.3389/fcvm.2021.676954

Table 2.

CYP2C19 genotypes distribution and P2Y12 receptor inhibitors selection.

Items RT n = 100 GT n = 201
CYP2C19 genotypes
LOF alleles carriers, N (%)
*2/*2 NA 20 (10.0)
*3/*3 NA 2 (1.0)
*2/*3 NA 15 (7.5)
*1/*2 NA 54 (26.9)
*1/*3 NA 24 (11.9)
Non-LOF alleles carriers, N (%)
*1/*1 NA 86 (42.8)
P2Y12 receptor inhibitors
Clopidogrel 75 (75.0) 86 (42.8)
Ticagrelor 25 (25.0) 115 (57.2)

RT, routine treatment group; GT, genotype-guided treatment group; LOF, loss-of-function.